We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
Turnover
90.24%
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+11.62%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.1%
AUM
$409M
AUM Growth
-$44.1M
(-9.7%)
Cap. Flow
-$59.6M
Cap. Flow
% of AUM
-14.56%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
781
New
279
Increased
97
Reduced
120
Closed
283
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$10.8M |
| 2 |
Microsoft
MSFT
|
+$7.69M |
| 3 |
TSMC
TSM
|
+$6.92M |
| 4 |
AbbVie
ABBV
|
+$6.78M |
| 5 |
Nikola Corporation Common Stock
NKLA
|
+$6.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$49.3M |
| 2 |
Biogen
BIIB
|
+$6.69M |
| 3 |
Accenture
ACN
|
+$6.42M |
| 4 |
Target
TGT
|
+$5.14M |
| 5 |
Walt Disney
DIS
|
+$4.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Consumer Discretionary | 16.31% |
| 3 | Healthcare | 16% |
| 4 | Industrials | 8.72% |
| 5 | Financials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.93T
| $14.9M | 3.63% |
70,700
+36,600
| +107% | +$7.69M |
2020 Q2
1 quarter
|
|
|
2
Apple
AAPL
$5.01T
| $11.5M | 2.81% |
+99,200
| New | +$10.8M |
2020 Q3
0 quarters
|
|
3
Zoom
ZM
$27.5B
| $7.7M | 1.88% |
+16,382
| New | +$5.24M |
2020 Q3
0 quarters
|
|
|
4
TSMC
TSM
$2.14T
| $7.38M | 1.8% |
+91,016
| New | +$6.92M |
2020 Q3
0 quarters
|
|
|
5
AbbVie
ABBV
$504B
| $7.33M | 1.79% |
83,700
+72,023
| +617% | +$6.78M |
2019 Q4
3 quarters
|
|
6
iShares Russell 2000 ETF
IWM
$76.2B
| $7M | 1.71% |
46,720
+3,620
| +8% | +$545K |
2019 Q4
3 quarters
|
|
7
Alibaba
BABA
$271B
| $5.35M | 1.31% |
18,200
+7,800
| +75% | +$2.06M |
2020 Q2
1 quarter
|
|
8
American Express
AXP
$212B
| $4.93M | 1.21% |
49,197
+25,017
| +103% | +$2.46M |
2019 Q4
3 quarters
|
|
9
Moderna
MRNA
$87B
| $4.13M | 1.01% |
+58,406
| New | +$4.07M |
2020 Q3
0 quarters
|
|
10
Marvell Technology
MRVL
$205B
| $3.71M | 0.91% |
93,500
+43,500
| +87% | +$1.6M |
2020 Q1
2 quarters
|
|
11
Tesla
TSLA
$1.4T
| $3.65M | 0.89% |
+25,560
| New | +$3.02M |
2020 Q3
0 quarters
|
|
12
TJX Companies
TJX
$162B
| $3.48M | 0.85% |
62,512
-200
| -0.3% | -$10.8K |
2019 Q4
3 quarters
|
|
|
13
DELISTED
Nikola Corporation Common Stock
NKLA
| $3.47M | 0.85% |
+5,649
| New | +$6.58M |
2020 Q3
0 quarters
|
|
14
Invesco QQQ Trust
QQQ
$475B
| $3.36M | 0.82% |
+12,100
| New | +$3.28M |
2020 Q3
0 quarters
|
|
15
CVS Health
CVS
$118B
| $3.29M | 0.8% |
56,300
+49,200
| +693% | +$3.06M |
2019 Q3
4 quarters
|
|
|
ATVI
16
DELISTED
Activision Blizzard
ATVI
| $3.08M | 0.75% |
38,100
+30,034
| +372% | +$2.44M |
2020 Q2
1 quarter
|
|
17
Vertex Pharmaceuticals
VRTX
$127B
| $3.08M | 0.75% |
+11,322
| New | +$3.12M |
2020 Q3
0 quarters
|
|
18
NIO
NIO
$8.57B
| $3.01M | 0.73% |
+141,714
| New | +$2.18M |
2020 Q3
0 quarters
|
|
19
Charter Communications
CHTR
$12.6B
| $2.95M | 0.72% |
4,720
-280
| -6% | -$165K |
2020 Q1
2 quarters
|
|
20
UnitedHealth
UNH
$360B
| $2.94M | 0.72% |
9,441
+8,229
| +679% | +$2.53M |
2020 Q1
2 quarters
|
|
21
Deere & Co
DE
$173B
| $2.76M | 0.67% |
12,463
+6,663
| +115% | +$1.29M |
2020 Q1
2 quarters
|
|
|
TIF
22
DELISTED
Tiffany & Co.
TIF
| $2.73M | 0.67% |
23,594
+21,800
| +1,215% | +$2.65M |
2020 Q2
1 quarter
|
|
23
Morgan Stanley
MS
$284B
| $2.73M | 0.67% |
56,401
+17,397
| +45% | +$876K |
2019 Q3
4 quarters
|
|
24
Union Pacific
UNP
$172B
| $2.68M | 0.65% |
13,600
+9,300
| +216% | +$1.73M |
2020 Q2
1 quarter
|
|
25
Royal Caribbean
RCL
$74.2B
| $2.64M | 0.65% |
40,800
+3,100
| +8% | +$183K |
2020 Q1
2 quarters
|
|
Similar funds
MCM
MFG
AFW
HSM
FWM
PIA
CCP
WCM
Bayesian Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Bayesian Capital Management held 781 positions worth $409M, down 9.7% from $453M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bayesian Capital Management withdrew a net $59.6M in Q3 2020, closing 283 positions and reducing 120 holdings. Its most notable exit was Biogen, an estimated $6.69M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Apple worth $11.5M.
- Bayesian Capital Management's largest Q3 2020 buy was Apple: 99,200 shares worth $11.5M.
- Bayesian Capital Management added most to Microsoft in Q3 2020, an estimated $7.69M increase.
- Bayesian Capital Management's biggest Q3 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $49.3M.
- Bayesian Capital Management fully exited Biogen in Q3 2020, selling an estimated $6.69M.
- Bayesian Capital Management's ten largest holdings make up 18% of its $409M portfolio in Q3 2020.
- Bayesian Capital Management opened 279 new positions and closed 283 in Q3 2020.
- Bayesian Capital Management's portfolio value fell 9.7% quarter-over-quarter to $409M.
Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.